These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20447580)

  • 1. Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients.
    Wein S; Voskoboinik A; Wein L; Billah B; Krum H
    J Card Fail; 2010 May; 16(5):432-8. PubMed ID: 20447580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation.
    Molhoek SG; Bax JJ; Bleeker GB; Boersma E; van Erven L; Steendijk P; van der Wall EE; Schalij MJ
    Am J Cardiol; 2004 Dec; 94(12):1506-9. PubMed ID: 15589005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of the use of cardiac resynchronization therapy beyond current guidelines.
    Van Bommel RJ; Delgado V; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Aug; 56(10):754-62. PubMed ID: 20797487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac resynchronization therapy by biventricular pacing. How many patients with left ventricular dysfunction are eligible?].
    Yang A; Wolpert C; Schimpf R; Schulz T; Krause U; Jung W; Herwig S; Jeong KM; Omran H; Lewalter T; Lüderitz B
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2259-63. PubMed ID: 12397540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding cardiac resynchronization for systolic heart failure to patients with mechanical dyssynchrony and atrial fibrillation.
    Ghanbari H; Hassunizadeh B; Machado C
    Rev Cardiovasc Med; 2005; 6(3):140-51. PubMed ID: 16195687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study.
    Fung JW; Zhang Q; Yip GW; Chan JY; Chan HC; Yu CM
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1288-92. PubMed ID: 16987381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failure.
    Mangiavacchi M; Gasparini M; Faletra F; Klersy C; Morenghi E; Galimberti P; Genovese L; Regoli F; De Chiara F; Bragato R; Andreuzzi B; Pini D; Gronda E
    Am Heart J; 2006 Feb; 151(2):477.e1-477.e6. PubMed ID: 16442917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in patients with a narrow QRS complex.
    Bleeker GB; Holman ER; Steendijk P; Boersma E; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2006 Dec; 48(11):2243-50. PubMed ID: 17161254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.